SEC Form 4 · accession 0001209191-16-153442
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonard S Jacob
Director
Period of report
Dec 1, 2016
Accepted (ET)
Dec 5, 2016 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 1, 2016 | M | 20,000 | $1.23 | A | 238,885 | D | |
| Common Stock | Dec 1, 2016 | S | 20,000 | $1.9708 | D | 218,885 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.23 | Dec 1, 2016 | M | 20,000 | D | — | Jan 16, 2017 | Common Stock | 20,000 | 0 | D |
Explanation of responses
- F1The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- F2The options vested and became exercisable one year following the grant date, which was January 16, 2007.